| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 27, 2004
Accepted on April 25, 2005
Department of Metabolic Medicine (G.A.B., W.S.D., S.J.D., K.G.M., J.V.G., P.H.J., W.M.K., M.A.G.), and Division of Investigative Science (S.R.B.), Hammersmith Campus, Imperial College London, London W12 0NN, United Kingdom
* To whom correspondence should be addressed. E-mail: s.bloom{at}imperial.ac.uk.
Nociceptin or Orphanin FQ (N/OFQ) and its receptor NOP1 are expressed in hypothalamic nuclei involved in energy homeostasis. N/OFQ administered by intracerebroventricular (ICV) or arcuate nucleus (ARC) injection increases food intake in satiated rats. The mechanisms by which N/OFQ increases food intake are unknown. We hypothesized that N/OFQ may regulate hypothalamic neurons containing peptides involved in the control of food intake such as cocaine and amphetamine regulated transcript (CART),
-melanocyte stimulating hormone (
-MSH), neuropeptide-Y (NPY) and agouti related protein (AgRP).
We investigated the ability of N/OFQ to alter the release of CART,
-MSH, NPY and AgRP using ex vivo medial basal hypothalamic explants. Incubation of hypothalamic explants with N/OFQ (1, 10, 100 nM) resulted in significant changes in CART and AgRP release. One hundred nanomolar N/OFQ caused a 33% decrease in release of CART (55-102)-immunoreactivity (-IR) and increased release of AgRP-IR to 163%, but produced no change in either
-MSH-IR or NPY-IR. Double immunocytochemistry (ICC) / in situ hybridization (ISH) demonstrated that CART-IR and NOP1 mRNA are co-localized throughout the hypothalamus in particular in the paraventricular nucleus, lateral hypothalamus, zona incerta and ARC, providing an anatomical basis for N/OFQ action on CART release. Dual ISH demonstrated that AgRP neurons in the ARC also express the NOP1 receptor. Our data suggests that nociceptin via the NOP1 receptor, may increase food intake by decreasing the release of the anorectic peptide CART and increasing the release of the orexigenic peptide AgRP.
This article has been cited by other articles:
![]() |
J. R. C. Parkinson, W. S. Dhillo, C. J. Small, O. B. Chaudhri, G. A. Bewick, I. Pritchard, S. Moore, M. A. Ghatei, and S. R. Bloom PYY3-36 injection in mice produces an acute anorexigenic effect followed by a delayed orexigenic effect not observed with other anorexigenic gut hormones Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E698 - E708. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Smith, M. Patterson, W. S. Dhillo, S. R. Patel, N. M. Semjonous, J. V. Gardiner, M. A. Ghatei, and S. R. Bloom Neuropeptide S Stimulates the Hypothalamo-Pituitary-Adrenal Axis and Inhibits Food Intake Endocrinology, July 1, 2006; 147(7): 3510 - 3518. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |